Edges in Network
| Network | GSE16446_egf1520 - GSE16446 - SiGN-BN HC+Bootstrap |
| Network Description | Predicting the efficacy of anthracyclines in breast cancer (BC) patients: The results of the TOP trial |
| Node | RBP1 |
| Upstream (Parents) |
|---|
| (<<) ATP2C2 → RBP1 |
| (<<) BCL2L13 → RBP1 |
| (<<) BMPR1A → RBP1 |
| (<<) BPGM → RBP1 |
| (<<) CXADR → RBP1 |
| (<<) CYB5R3 → RBP1 |
| (<<) DAZAP2 → RBP1 |
| (<<) EGFR → RBP1 |
| (<<) EPHB2 → RBP1 |
| (<<) EPHB3 → RBP1 |
| (<<) FBXO32 → RBP1 |
| (<<) FZD1 → RBP1 |
| (<<) HSP90AB1 → RBP1 |
| (<<) ITGB4 → RBP1 |
| (<<) KREMEN1 → RBP1 |
| (<<) KRT6B → RBP1 |
| (<<) LRP5 → RBP1 |
| (<<) MAPK13 → RBP1 |
| (<<) MLX → RBP1 |
| (<<) PPIF → RBP1 |
| (<<) RARG → RBP1 |
| (<<) RHBDL1 → RBP1 |
| (<<) RHOA → RBP1 |
| (<<) RPS6KB1 → RBP1 |
| (<<) SCG5 → RBP1 |
| (<<) SHC1 → RBP1 |
| (<<) SLC16A6 → RBP1 |
| (<<) TAGLN2 → RBP1 |
| (<<) UBE2E3 → RBP1 |
| (<<) UGDH → RBP1 |
| Downstream (Children) |
|---|
| (no edges) |
